Johnson & Johnson says its ketamine-based drug can treat depression ...Middle East

Quartz - Economy
Johnson & Johnson says its ketamine-based drug can treat depression
Johnson & Johnson said on Monday that it submitted an application to the U.S. Food and Drug Administration (FDA) to expand the approved used of its ketamine-based drug Spravato to be used as a standalone alone therapy for treatment resistant depressionRead more...

Hence then, the article about johnson johnson says its ketamine based drug can treat depression was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson says its ketamine-based drug can treat depression )

Apple Storegoogle play

Last updated :

Also on site :